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Background:  To determine the prevalence of β-
thalassaemia carriers in twin-cities of Islamabad and 
Rawalpindi. 
Methods:  In this descriptive  study, people were 
motivated to get screened for β- thalassaemia trait. 
Hemoglobin level, RBC count, MCV, MCH was measured. 
Hemoglobin electrophoresis was performed if MCH was 
less than 27pg, MCV less than 75fl and RBC count more 
than 5 million. If HbA2 was 3.5%or higher, thalassaemia 
trait was diagnosed. 
Results: A total of 2101 people were screened in camps 
held at offices of Federal Ministry of Health & Pakistan 
Post, two villages( Terlai & Phoolgran) in the suburbs of 
Islamabad, Fatima Jinnah and Foundation Universities 
and other educational institutions. 85(4.05%) were found to 
be carriers of β-thalassaemia. 
Conclusion:  β-Thalassaemia Trait has a carrier 
frequency of around 4% in twin-cities and suburbs. 
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Introduction 
      Thalassaemias are genetic disorders characterized 
by reduced synthesis of either alpha or beta chain of 
hemoglobin. Most of the patients with severe forms of 
β- thalassaemia i.e. thalassaemia major need lifelong 
treatment including blood transfusion, iron chelation 
etc. β - thalassaemia is a preventable disease through 
comprehensive strategy at community level and this 
fact has been proved by Cypriot and Greek experience 
with prevention of this disease. 1-3 
 Preventive strategies involving identification 
of carriers, genetic counselling and prenatal diagnosis 
have now almost eliminated the risk of new children 
with homozygous thalassaemia in countries which 
were once known for the highest prevalence of 
thalassaemia. 4 WHO  recommends countries with 
heavy burden of non-communicable disease to have 
national programs for prevention. A careful estimate 
of the carrier frequency in the community through a 
survey involving large population is required.5 
Subjects and Methods 
      In Rawalpindi and Islamabad, camps were held at 
Federal Government offices including Federal 
Ministry of Health and Pakistan Post, at two villages 
Terlai and Phoolgran and educational institutions. 
People were informed about the genetic nature of the 
disease, its severity and cumbersome lifelong 
treatment, the inheritance pattern and possibility of an 
individual to be carrier of the disease and a potential 
risk of having a child with thalassaemia major, if both 
parents are carriers. All people willing for screening 
were included in study irrespective of their age, 
gender or ethnic background. 
       Five ml blood sample was taken in EDTA bottle, 
labelled and saved for laboratory workup. 
Haemoglobin levels, RBC count, MCV, MCH were 
measured using an automated electronic haematology 
analyzer. Haemoglobin electrophoresis was performed 
if MCH was less than 27pg, MCV less than 75fl  and 
RBC count  more than 5 million. 6  If HbA2 was 3.5%or 
higher, they were labelled as thalassaemic trait and 
others were advised to undergo iron studies. All 
individuals identified as thalassaemia carriers were 
invited to thalassaemia center, counselled regarding 
the risk they could face and given written information 
both in Urdu and English including inheritance 
pattern and prevention of thalassaemia 
Results 
     Over a period of four years, from 2006 to 2010 a 
total number of 2101 people were screened Overall 
carrier rate was  4.05%,and was  higher in rural  
population( Table 1) 
Discussion 
    Identification of carriers is an essential part of 
prevention programs. Although a nationwide survey 
is required to know the real burden of disease, studies 
conducted on smaller number of subjects can be useful 
to estimate the burden of disease, particularly in a 
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country with limitation of resources and lack of 
efficient primary health infrastructure. 7 
Table 1:  Distribution of screened 






of health office, 
Islamabad 
237 9(3.79) 
Pakistan post,  
Islamabad  
406 12(2.96) 
Terlai village 206 21(10.19) 










Total 2101 85/2101(4.05%) 
                                
      A study, in thalassaemia patients’ families, 
revealed frequency  of consanguineous marriages in 
parents as first cousin marriages in 72%, second cousin 
marriages in 5% , distant cousins in 4% and unrelated 
in 19%. 8In our study 4.06% people were found to be 
carriers of β-thalassaemia which is  comparable to the 
earlier reports (Table 2). Overall estimation of carrier 
rate at national level is around 5%. However there is 
variation in the prevalence of thalassaemia in different 
parts of country. There is, relatively, a high prevalence 
in Pathans(7.9%) as compared to Punjabis(3.26%). 9-14 
In a family having a patient of β-thalassaemia major 
(extended family) the prevalence of beta thalassaemia 
trait is higher (31%).15Our neighbouring countries also 
have more or less a comparable prevalence rate of β-
thalassaemia carriers. Indian Punjab 3.5%, Saudi 
Arabia 3.4%, Southern China 2.54% and  Hong Kong 
3.4%.16-18 
Table 2: Carrier Frequency in Pakistan 
Population Region β-thalassaemia 
Trait 
Pathans 12 Peshawar / 
Rawalpindi 
7.96% 
Pakistani 8 Rawalpindi 3.9% 
Punjabi 12 Rawalpindi  3.3% 
Pakistani 9 Karachi 3.4% 
Pakistani 12 Rawalpindi/ 
Peshawar 
5.4% 
      A carrier rate of 4% is considered to be among the 
high prevalence which can result in heavy burden of 
disease particularly in the absence of an effective 
preventive strategy. First part of such preventive 
program should be “targeted screening” involving 
families already having a patient with β-thalassaemia. 
It can be cost-effective,convenient and easily 
acceptable intervention to reduce the burden of 
disease.15 
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